The efficacy and safety of adding on or switching to peginterferon α-2b in HBeAg-positive chronic hepatitis B patients with long-term entecavir treatment: a multicentre randomised controlled trial.
Qiankun HuXun QiYiqi YuYueqiu GaoXin-Xin ZhangQianqian WangXueyun ZhangYunhui ZhuoJing LiJi-Ming ZhangLiang ChenYu-Xian HuangPublished in: Alimentary pharmacology & therapeutics (2022)
Chinese Clinical Trial Registry (www.chictr.org.cn, identifier: ChiCTR-IPR-17012055).